Facebook Twitter Instagram
    RECENT:
    • EDD 2022 – Spain
    • EDD 2022 – Russia
    • EDD 2022 – Portugal
    • EDD 2022 – Germany
    • EDD 2022 – France
    • EDD 2022 – Croatia
    • EDD 2022 – Belgium
    • EDD 2022 – Flyer
    • EDD 2021 – Italia
    • EDD 2021 – Belgium
    Facebook Twitter Instagram
    Monday, January 30
    European Depression Association
    Facebook Twitter Instagram
    • Home
    • About us
    • Board
    • Manifesto
    • EDD 2022
    • Previous editions
    • Articles
    • Links
    • Contact US
    European Depression Association
    Home»Articles»Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants

    Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants

    0
    By Webmaster on 12 May 2019 Articles
    Share
    Facebook Twitter LinkedIn WhatsApp
    Journal of Affective Disorders, Vol. 234, 2018, Pages 131-138 https://doi.org/10.1016/j.jad.2018.02.085
    Michele Fornaro, Annalisa Anastasia, Francesco Monaco, Stefano Novello, Andrea Fusco, Felice Iasevoli, Domenico De Berardis, Nicola Veronese, Marco Solmi, Andrea de Bartolomeis

    Highlights

    • Treatment-emergent mania (TEM) has been reported inconsistently among Bipolar Disorder (BD) depressed patients receiving antidepressants.•
    • TEM occurred in 38.46% of the assessed cases.•
    • A typical antipsychotics (p = .005), lithium (≤ .001), cyclothymic/irritable/hyperthymic temperaments (p = ≤ .001; p = .001; p = .003, respectively), rapid-cycling (p = .005) and depressive mixed features (p = .003) differed between TEM+vs. TEM− patients upon descriptive statistics but not multivariate regression.

    Click to link to the article
    Background

    Treatment-emergent affective switch (TEAS), including treatment-emergent mania (TEM), carry significant burden in the clinical management of bipolar depression, whereas the use of antidepressants raises both efficacy, safety and tolerability concerns. The present study assesses the prevalence and clinical correlates of TEM in selected sample of Bipolar Disorder (BD) Type-II (BD-II) acute depressionoutpatients.

    Methods

    Post-hoc analysis of the clinical and psychopathological features associated with TEM among 91 BD-II depressed outpatients exposed to antidepressants.

    Results

    Second-generation antipsychotics (SGA) (p = .005), lithium (≤ .001), cyclothymic/irritable/hyperthymic temperaments (p = ≤ .001; p = .001; p = .003, respectively), rapid-cycling (p = .005) and depressive mixed features (p = .003) differed between TEM+ cases vs. TEM− controls. Upon multinomial logistic regression, the accounted psychopathological features correctly classified as much as 88.6% of TEM+ cases (35/91 overall sample, or 38.46% of the sample), yet not statistically significantly [Exp(B) = .032; p = ns]. Specifically, lithium [B = − 2.385; p = .001], SGAs [B = − 2.354; p = .002] predicted lower rates of TEM+ in contrast to the number of lifetime previous psychiatric hospitalizations [B = 2.380; p = .002], whereas mixed features did not [B = 1.267; p = ns].

    Limitations

    Post-hoc analysis. Lack of systematic pharmacological history record; chance of recall bias and Berkson’s biases. Permissive operational criterion for TEM. Relatively small sample size.

    Conclusions

    Cyclothymic temperament and mixed depression discriminated TEM+between TEM− cases, although only lithium and the SGAs reliably predicted TEM+/− grouping. Larger-sampled/powered longitudinal replication studies are warranted to allow firm conclusions on the matter, ideally contributing to the identification of clear-cut sub-phenotypes of BD towards patient-tailored-pharmacotherapy.

    Share. Facebook Twitter LinkedIn WhatsApp

    Related Articles

    “G.T. Mixed States Rating Scales”, or “G.T. MSRS”

    22 May 2019

    Early Intervention in Bipolar Disorder

    13 May 2019

    Depression and suicide on Gotland: an intensive study of all suicides before and after a depression-training programme for general practitioners

    13 May 2019

    Comments are closed.

    THE HANDBOOK ON DEPRESSION AND MOOD DISORDER

    Croatian versionFrench versionItalian versionLatvian versionPortuguese versionRussian versionSpanish versionTurkey version

    Facebook Twitter Instagram LinkedIn
    • Home
    • About us
    • Contact us
    • Cookie Policy (EU)
    © 2023 European Depression Association. Designed by AR Engineering.

    Type above and press Enter to search. Press Esc to cancel.

    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View preferences
    {title} {title} {title}